World Heart Summit 2025

From Science to Policy and Action

The 10th edition of the World Heart Summit took place in Geneva, Switzerland, the heart of global health diplomacy in 2025, ahead of the 78th World Health Assembly.

Global leaders and experts from government, civil society, academia and the private sector came together to advance solutions for cardiovascular health worldwide.


Together, we continue to drive progress towards better heart health for all.

The World Heart Summit 2025 was accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 12 CE points, equivalent to 12 hours of effective education time.

Session recordings are available below as part of the World Heart Summit 2025 programme.

PROGRAMME OF THE WORLD HEART SUMMIT 2025

Choose which day's agenda you want to view

Saturday, 17 May 2025

Time Sessions
8:30 – 9:00

Welcome & Registration

9:00 – 9:20

Welcome to World Heart Summit 2025, Exchange of Livery Collar, Introduction to WHS 2025

The 10th World Heart Summit opened with inspiring addresses from World Heart Federation leaders and marked significant leadership transitions. New CEO Finn Jarle Rode emphasized the urgent global mission to combat cardiovascular disease—the world’s leading cause of death—highlighting the importance of early diagnosis, public awareness, and global collaboration. Outgoing president Prof. Daniel Piñeiro was honored for his impactful tenure, including advancements in advocacy, partnerships, and education programs such as the Leadership in Advocacy and Communication and Emerging Leaders Program. Incoming president Prof. Jagat Narula underscored the shared responsibility to advance cardiovascular health globally, invoking compassion, equity, and policy leadership. COO Borjana Pervan framed the summit’s importance ahead of the UN High-Level Meeting on NCDs, calling for bold, measurable global targets to reduce CVD mortality. This opening set a powerful tone for two days of global dialogue on cardiovascular health diplomacy.

Jagat Narula
Jagat Narula President World Heart Federation
Finn Jarle Rode
Finn Jarle Rode CEO World Heart Federation
9:20 – 10:30

UN High-Level Meeting 2025 WHF Proposal

This pivotal session at the World Heart Summit 2025 focused on shaping the global cardiovascular agenda ahead of the upcoming UN High-Level Meeting on Non-Communicable Diseases (NCDs). Leading experts, including Dr. Jagat Narula, Prof. Srinath Reddy, Prof. Pablo Perel, Prof. Prabhakaran Dorairaj, Dr. Slim Slama, and Dr. Bente Mikkelsen, critically analyzed the gaps in achieving Sustainable Development Goal 3.4 to reduce premature NCD mortality by 2030. The panel emphasized the need to extend targets beyond 2030, adopt a life-course approach, address multimorbidity, and strengthen primary healthcare through integrated, community-based, and transdisciplinary models. Discussions addressed the urgent need for sustainable financing, equity across income levels, and stronger global governance, with particular attention to commercial determinants like ultra-processed foods and tobacco. The session called for bold, evidence-based policy changes, innovative health system redesign, and expanded implementation research to advance universal cardiovascular health.

Srinath Reddy
Srinath Reddy Past President Public Health Foundation of India
Jagat Narula - Moderator
Jagat Narula – Moderator President World Heart Federation
Prabhakaran Dorairaj
Prabhakaran Dorairaj WHF President-Elect, Executive Director Centre for Chronic Disease Control, New Delhi
Pablo Perel
Pablo Perel Senior Science Advisor World Heart Federation
Bente Mikkelsen
Bente Mikkelsen WHF Advocacy Committee Chair and Director, Global Engagement Strategies St. Jude Children’s Research Hospital
Slim Slama
Slim Slama CEO World Innovation Summit for Health, Qatar Foundation
10:30 – 11:00

Keynote address: Legacy of the ‘Go Red For Women’ campaign

This impactful session at the World Heart Summit 2025, moderated by WHF CEO Finn Jarle Rode and COO Borjana Pervan, spotlighted global gender disparities in cardiovascular health. Featuring Nancy Brown, CEO of the American Heart Association, and Prof. Satyendra Tiwari, the session emphasized the urgent need to address persistent gaps in diagnosis, treatment, and research for women affected by cardiovascular disease (CVD). Brown presented the Go Red for Women campaign, highlighting its global reach through advocacy, awareness, and groundbreaking initiatives like Research Goes Red and the Go Red Venture Fund. Prof. Tiwari reinforced the importance of extending these efforts to low- and middle-income countries. The discussion called for stronger global collaboration, investment in women-focused research, early diagnosis, and equitable care to advance cardiovascular health equity for women worldwide.

Nancy Brown - Honoree
Nancy Brown – Honoree CEO American Heart Association (AHA)
Satyendra Tiwari - Moderator
Satyendra Tiwari – Moderator Professor Department of Cardiology Sanjay Gandhi Postgraduate Institute of Medical Sciences
Finn-Jarle Rode - Moderator
Finn-Jarle Rode – Moderator CEO World Heart Federation
Borjana Pervan - Moderator
Borjana Pervan – Moderator COO World Heart Federation
11:00 – 11:30

Break

11:30 – 12:30

Addressing multimorbidity in the context of CVD

At the World Heart Summit 2025, this expert panel, moderated by Michelle Winokur (Executive Director, International Atherosclerosis Society), explored the rising global challenge of multimorbidity in cardiovascular disease (CVD). Prof. Dorairaj Prabhakaran (WHF President-Elect, Centre for Chronic Disease Control, New Delhi) opened with a case study highlighting the complex intersection of CVD with diabetes, obesity, renal disease, and social determinants of health. Panelists—including Dr. Taskeen Khan (World Heart Federation), Bruce Neal (The George Institute for Global Health, Australia), Gemma Figtree (University of Sydney), Shreeram Aradhye (Novartis), Dr. José R. Gonzalez Juanatey (University Clinical Hospital, Santiago de Compostela), and Richard Chazal (Lee Health Heart Institute)—emphasized health system redesign, digital innovation, team-based care, and integrated prevention strategies. The session underscored the urgent need for scalable, context-specific policies, food system interventions such as salt substitution, and stronger patient engagement to reduce the burden of multimorbidity worldwide.

Michelle Winokur - Moderator
Michelle Winokur – Moderator Executive Director International Atherosclerosis Society
Prabhakaran Dorairaj
Prabhakaran Dorairaj WHF President-Elect, Executive Director Centre for Chronic Disease Control, New Delhi
Taskeen Khan
Taskeen Khan WHF Advocacy Committee Member World Heart Federation
Bruce Neal
Bruce Neal Executive Director The George Institute for Global Health, Australia
Gemma Figtree
Gemma Figtree Professor of Medicine University of Sydney
Shreeram Aradhaye
Shreeram Aradhaye President, Development and Chief Medical Officer Novartis
José Ramon Juanatey
José Ramon Juanatey Head of the Cardiology Service and CCU University Clinical Hospital, Santiago de Compostela
Richard Chazal
Richard Chazal Senior Cardiologist and Medical Director for Quality, Transformation, Innovation Lee Health Heart Institute
12:30 – 13:15

Primacy of primary care in combating CVD

This high-level session at World Heart Summit 2025, moderated by Taskeen Khan (WHF Advocacy Committee Member), explored the pivotal role of primary care in hypertension control and cardiovascular disease (CVD) prevention worldwide. Dr. Tom Frieden (Resolve to Save Lives) emphasized the urgent need for simple, scalable, data-driven solutions to achieve global hypertension control and prevent millions of deaths. Dr. Jérôme Salomon (WHO Assistant Director General) outlined workforce, integration, and financing gaps that hinder progress in many countries. Prof. Amam Mbakwem (University of Lagos, WHF Vice-President) addressed barriers faced in sub-Saharan Africa, while Dr. Rony Shimony (Mount Sinai, Atria Institute) underscored the empowerment of primary care teams to meet treatment targets. Eliezer Lappots-Abreu (Health Horizons International Foundation) highlighted the intersection of human rights, immigration, and equitable access to care. Dana Burduja (European Investment Bank) presented innovative financial models supporting health infrastructure, while Mark Barone (ForumCCNTs, Brazil) showcased multisectoral partnerships improving hypertension control in Brazil. The session called for global leadership, financing, and accountability ahead of the 2025 UN High-Level Meeting on NCDs.

Taskeen Khan - Moderator
Taskeen Khan – Moderator WHF Advocacy Committee Member World Heart Federation
Tom Frieden
Tom Frieden President and CEO Resolve To Save Lives
Jérôme Salomon
Jérôme Salomon Assistant Director General ADG SDG World Health Organization
Amam Mbakwem
Amam Mbakwem WHF Vice-President and Professor of Medicine University of Lagos
Rony Shimony
Rony Shimony Director of Cardiology at Atria Institute Mount Sinai – New York
Eliezer Lappots-Abreu
Eliezer Lappots-Abreu President and Executive Director Health Horizons International Foundation
Mark Barone
Mark Barone Founder and General Manager Intersectoral Forum of NCCs/NCDs in Brazil (ForumCCNTs)
Dana Burduja
Dana Burduja Head of Life Sciences and Health Division European Investment Bank
13:15 – 14:15

Lunch Break

14:15 – 15:00

Innovations in Drug Interventions for CVD at Primary Healthcare Level

This forward-looking session at the World Heart Summit 2025, moderated by Prof. Jagat Narula (President, World Heart Federation), explored cutting-edge advances in cardiovascular pharmacotherapy with a focus on primary care integration, adherence, and global accessibility. Dr. Lutz Hegemann (Novartis Global Health) emphasized innovative long-acting RNA-based therapies, health system strengthening, and community-based models to deliver care at scale, including programs across Rwanda, Vietnam, and sub-Saharan Africa. Prof. Tazeen H. Jafar (Duke-NUS, Singapore) presented evidence from community-led hypertension control models like COBRA, highlighting scalable task-shifting strategies in LMICs. Prof. Andrea Brandão (State University of Rio de Janeiro) advocated for simplified single-pill combinations to improve adherence in resource-limited settings. Dr. Sameer Bansilal (Alnylam Pharmaceuticals) outlined the promise of RNA therapeutics and annual dosing regimens to revolutionize prevention. The panel underscored the need for financing models, community engagement, and multisectoral partnerships to ensure innovations reach the most vulnerable populations worldwide.

Lutz Hegemann
Lutz Hegemann President of Global Health and Swiss Country Affairs Novartis Global Health
Tazeen H. Jafar
Tazeen H. Jafar Professor, Program in Health Services and Systems Research Duke-NUS Graduate Medical School Singapore
Jagat Narula - Moderator
Jagat Narula – Moderator President World Heart Federation
Andrea Brandão
Andrea Brandão Full Professor of Cardiology State University of Rio de Janeiro, Brazil
Sameer Bansilal
Sameer Bansilal Vice President- Global Head – TTR Medical Affairs Alnylam Pharmaceuticals
15:00 – 15:45

Financial protection from catastrophic costs of CVD: What does it take to reduce CVD by 50%?

This insightful session at the World Heart Summit 2025, moderated by Payal Kohli (Johns Hopkins University / Duke University), explored global strategies to address multimorbidity in cardiovascular care. Prof. Bente Mikkelsen (WHF Advocacy Chair, St. Jude Children’s Research Hospital) emphasized the urgent need for systemic health reforms, stronger primary care, and trust-building in low- and middle-income countries. Hyvelle Ferguson-Davis (Heart Sistas) and Dr. Lillian Mbau (Kenya Cardiac Society) underscored the importance of community-based education, health literacy, and culturally sensitive patient engagement to improve adherence and equity. Jeremiah Mwangi (World Heart Federation) highlighted WHF’s advocacy efforts to align global policy with practical implementation. Prof. Athena Poppas (Brown University) and Dr. John Harold (Cedars-Sinai, ACC Past-President) stressed the importance of integrated care models, early detection, digital innovations, and provider collaboration across specialties. The panel called for holistic, patient-centered approaches, scalable solutions, and stronger global policy action to confront the growing burden of cardiovascular multimorbidity worldwide.

Payal Kohli - Moderator
Payal Kohli – Moderator Associate Adjunct Professor in Cardiology Department of Medicine, Johns Hopkins University / Department of Medicine, Duke University
Bente Mikkelsen
Bente Mikkelsen WHF Advocacy Committee Chair and Director, Global Engagement Strategies St. Jude Children’s Research Hospital
Hyvelle Ferguson-Davis
Hyvelle Ferguson-Davis Founder Heart Sistas
Lillian Mbau
Lillian Mbau WHF Advocacy Committee member and CEO Kenya Cardiac Society
Jeremiah Mwangi Director of Policy and Advocacy World Heart Federation
Athena Poppas
Athena Poppas Chief of Cardiology and Director Brown University Health Cardiovascular Institute
John Harold
John Harold Past-President, American College of Cardiology and Cardiologist Cedars-Sinai Smidt Heart Institute, Los Angeles
15:45 – 16:15

Break

16:15 – 17:00

Launch of the WH Report

In this pivotal session at the World Heart Summit 2025, moderated by Johanna Ralston (CEO, World Obesity Federation), the World Heart Report 2025 was officially launched, focusing on the complex relationship between obesity and cardiovascular disease (CVD). Francisco Lopez-Jimenez (Mayo Clinic) presented key findings on obesity’s rapid global rise, its causal role in multiple cardiovascular conditions, and the urgent need to reframe obesity as a complex chronic disease rather than a lifestyle choice. Panelists—including Mariachiara di Cesare (University of Essex), Fausto Pinto (Centro Hospitalar Universitário de Lisboa Norte), Pamela Cipriano (International Council of Nurses), and David Wood (University of Galway)—discussed multidisciplinary care models, upstream social determinants, the role of nursing in primary care, public health policy, global food systems, and the need for stronger political action. The session emphasized prevention, equity, and integrated clinical and policy interventions to address the obesity-driven CVD epidemic worldwide.

Mariachiara di Cesare
Mariachiara di Cesare Professor in Population Studies and Global Health University of Essex
Johanna Ralston - Moderator
Johanna Ralston – Moderator CEO World Obesity Federation
Francisco Lopez-Jimenez
Francisco Lopez-Jimenez Chair, Division of Preventive Cardiology Mayo Clinic
Fausto Pinto
Fausto Pinto Diretor Dept Coração e Vasos do CHULN Centro Hospitalar Universitário de Lisboa Norte
Pamela Cipriano
Pamela Cipriano President International Council of Nurses
David Wood
David Wood Adjunct Professor of Preventive Cardiology at the National Institute of Prevention and Cardiovascular Health University of Galway

THE WORLD HEART SUMMIT 2025 WAS MADE POSSIBLE BY THE FOLLOWING PARTNERS

WORLD HEART SUMMIT 2024 – HIGHLIGHTS